Major Depressive Disorder
Conditions
Interventions
Escitalopram
Sponsors
St. Marianna University School Of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) The patient with major depressive disorder to meet a criteria of DSM-V 2) The patient who is over 20 years old at the agreement acquisition 3) The patient who understands enough the explanation about this examination and agrees on this study
Exclusion criteria
Exclusion criteria: 1) The patient with a history of hypersensitivity for the ingredient of the study drug 2) The patient who is taking a monoamine oxidase (MAO) inhibitor or the patient who stops taking the drug within 14 days 3) The patient who is taking Pimozide 4) The patient who has QT interval over 500 msec 5) The patient who has long QT syndrome and arrhythmia to need treatment or the heart disorder (coronary artery disease, myocardial desease, valve disorder and heart failure) 6) The patient who is regarded as the inappropriate person by a doctor who is in charge of the examination
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Confirmation of the QT prolonged with taking Escitalopram | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)Correlation of the QT intervals measured by 12 instruction and mobile electrocardiograph 2)Prevalence of the QT value over 500msec 3)Observation of the QT value area according to the subjects background factor | — |
Countries
Japan
Contacts
Public ContactKenichi Osada
St. Marianna University School Of Medicine Neuropsychiatry
Outcome results
None listed